GLENMARK.NS - Glenmark Pharmaceuticals Limited

NSE - NSE Real Time Price. Currency in INR
Currency in INR

Valuation Measures

Market Cap (intraday) 5150.2B
Enterprise Value 3181.28B
Trailing P/E 14.89
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)1.58
Price/Book (mrq)2.75
Enterprise Value/Revenue 31.91
Enterprise Value/EBITDA 610.56

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar 31, 2017
Most Recent Quarter (mrq)Sep 30, 2017

Profitability

Profit Margin 10.61%
Operating Margin (ttm)16.45%

Management Effectiveness

Return on Assets (ttm)7.45%
Return on Equity (ttm)19.82%

Income Statement

Revenue (ttm)95.06B
Revenue Per Share (ttm)336.95
Quarterly Revenue Growth (yoy)1.50%
Gross Profit (ttm)64.6B
EBITDA 17.17B
Net Income Avi to Common (ttm)10.08B
Diluted EPS (ttm)35.72
Quarterly Earnings Growth (yoy)-6.90%

Balance Sheet

Total Cash (mrq)15.02B
Total Cash Per Share (mrq)53.21
Total Debt (mrq)44.98B
Total Debt/Equity (mrq)82.54
Current Ratio (mrq)2.24
Book Value Per Share (mrq)193.13

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A

Trading Information

Stock Price History

Beta N/A
52-Week Change 3-40.91%
S&P500 52-Week Change 317.09%
52 Week High 3972.95
52 Week Low 3530.20
50-Day Moving Average 3584.32
200-Day Moving Average 3621.64

Share Statistics

Avg Vol (3 month) 3953.9k
Avg Vol (10 day) 3860.52k
Shares Outstanding 5282.2M
Float 150.7M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short 3N/A
Short Ratio 3N/A
Short % of Float 3N/A
Shares Short (prior month) 3N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 32.00
Trailing Annual Dividend Yield 30.37%
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 22/1
Last Split Date 3Sep 10, 2007